HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $10 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Ocular Therapeutix (NASDAQ:OCUL) and maintained a $10 price target.
June 08, 2023 | 10:40 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating on Ocular Therapeutix (NASDAQ:OCUL) and maintained a $10 price target.
The reiteration of the Buy rating and maintenance of the $10 price target by HC Wainwright & Co. analyst Yi Chen indicates a positive outlook for Ocular Therapeutix. This news is likely to have a positive impact on the stock price in the short term as it shows confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100